$EMAMILTD : A Niche FMCG Value Buy Post-Correction

$EMAMILTD has significantly underperformed its FMCG peers and the broader market, dropping over 30% over the past year. This sharp decline was triggered by temporary headwinds, including sluggish domestic volume growth, unseasonal weather patterns, and geopolitical tensions in West Asia. However, this correction presents a compelling valuation re-rating opportunity for investors. Tailwinds for Core Brands: While legacy winter portfolios like BoroPlus face risks from milder seasons, summer-centric flagship brands—specifically Navratna and Dermicool—are experiencing a strong resurgence. A clear demand surge in the early months of the fiscal year points to a robust double-digit volume growth trajectory for these critical revenue pillars. D2C Scale-Up and Urban Premiumisation: To capture higher-margin premium consumers, Emami is aggressively expanding its digital-first, newly acquired brands like The Man Company and Brillare, which are projected to grow by over 30%. Concurrently, the company is upgrading its distribution reach in urban markets to aggressively support these margin-accretive products. Structural shifts in the distribution channel mix are paying off, with modern, high-growth channels like quick commerce witnessing an impressive 70% surge in sales during Q4FY26. Organised trade now accounts for roughly 32% of the domestic sales mix, successfully driving premium consumer acquisition. Recent strategic moves, including the full acquisition of Axiom Ayurveda (entering the fruit juice market) and a controlling stake in IncNut, are set to unlock long-term value. Combined with tight cost controls and proactive pricing strategies, these additions will expand EBITDA margins and boost profitability. Despite a major Q4 setback caused by operational disruptions in UAE-based production, international operations have stabilized. Backed by streamlined logistics, international sales are projected to bounce back into strong double-digit growth starting from Q2FY27